ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 561,13
1,09%
Dow Jones
39 134,11
0,04%
DAX
18 290,66
0,31%
Brent Oil
86,545
1,69%
Bitcoin
63 588,89
1,58%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sio Gene Therapies Inc (SIOX)

  7. Sio Gene Therapies Inc (SIOX) Actualités

SIOX

Sio Gene Therapies (SIOX)

Sio Gene Therapies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SIOX
DateHeureSourceTitreSymboleSociété
02/02/202413h00GlobeNewswire Inc.Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per ShareNASDAQ:SIOXSio Gene Therapies Inc
25/04/202322h05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:SIOXSio Gene Therapies Inc
17/04/202322h17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SIOXSio Gene Therapies Inc
17/04/202322h14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SIOXSio Gene Therapies Inc
12/04/202314h52Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SIOXSio Gene Therapies Inc
06/04/202322h08Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:SIOXSio Gene Therapies Inc
06/04/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
17/03/202311h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SIOXSio Gene Therapies Inc
21/02/202322h06Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SIOXSio Gene Therapies Inc
14/02/202313h00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
14/02/202312h47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SIOXSio Gene Therapies Inc
13/02/202314h53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SIOXSio Gene Therapies Inc
10/02/202322h01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SIOXSio Gene Therapies Inc
09/02/202312h01Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:SIOXSio Gene Therapies Inc
14/12/202222h49GlobeNewswire Inc.Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionNASDAQ:SIOXSio Gene Therapies Inc
10/11/202213h00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
11/08/202213h00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
14/06/202213h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SIOXSio Gene Therapies Inc
14/06/202213h00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
28/04/202215h05TipRanksAnalyst Explains Why They Downgraded Their Rating on Sio Gene Therapies (SIOX)NASDAQ:SIOXSio Gene Therapies Inc
27/04/202222h25GlobeNewswire Inc.Sio Gene Therapies Provides Corporate UpdateNASDAQ:SIOXSio Gene Therapies Inc
11/02/202213h00GlobeNewswire Inc.Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
10/02/202223h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SIOXSio Gene Therapies Inc
02/02/202213h00GlobeNewswire Inc.Sio Gene Therapies to Present at the 18th Annual WORLDSymposium™ 2022NASDAQ:SIOXSio Gene Therapies Inc
31/01/202222h01GlobeNewswire Inc.Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO TransitionNASDAQ:SIOXSio Gene Therapies Inc
12/11/202113h00GlobeNewswire Inc.Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
11/11/202113h00GlobeNewswire Inc.Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s DiseaseNASDAQ:SIOXSio Gene Therapies Inc
01/11/202112h00GlobeNewswire Inc.Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 GangliosidosisNASDAQ:SIOXSio Gene Therapies Inc
21/10/202123h00GlobeNewswire Inc.Sio Gene Therapies Announces Reorganization of R&D GroupNASDAQ:SIOXSio Gene Therapies Inc
21/10/202114h56Dow Jones NewsSio Gene Therapies Gets FDA Fast-Track Designation for AXO-AAV-GM1 in GM1 GangliosidosisNASDAQ:SIOXSio Gene Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:SIOX

Dernières Valeurs Consultées

BIT
UC81CK
Unicredit Bank
DBI
I8NH
IN XTK 2 GERM
BIT
SXLF
Spdr S&p U.s. Financials...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés